Brought to you by 
Perrigo acquires ScarAway from Enaltus
15 Sep 2017
Executive Summary
Perrigo Co. PLC acquired US OTC scar management brand ScarAway from Enaltus LLC. The brand is expected to generate $10mm in sales in 2015 and be immediately accretive to EPS. The transaction further supports Perrigo's "base plus plus plus" strategy and strengthens its OTC portfolio in the US by expanding distribution and customer networks.
Deal Industry
- Medical Devices
-
Pharmaceuticals
- OTC, Consumer
-
Drug Delivery
- Topical Delivery
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Perrigo acquires ScarAway from Enaltus
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice